Product NDC: | 55154-3428 |
Proprietary Name: | Comtan |
Non Proprietary Name: | entacapone |
Active Ingredient(s): | 200 mg/1 & nbsp; entacapone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-3428 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020796 |
Marketing Category: | NDA |
Start Marketing Date: | 20000101 |
Package NDC: | 55154-3428-4 |
Package Description: | 100 POUCH in 1 CARTON (55154-3428-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-3428-6) |
NDC Code | 55154-3428-4 |
Proprietary Name | Comtan |
Package Description | 100 POUCH in 1 CARTON (55154-3428-4) > 1 TABLET, FILM COATED in 1 POUCH (55154-3428-6) |
Product NDC | 55154-3428 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | entacapone |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20000101 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | ENTACAPONE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |